abstract |
The invention relates to an injectable combination of two specific glycosaminoglycans, hyaluronic acid and chondroitin sulfate with cyclodextrins and the use of the described combination for the treatment of diseases associated with skeletal systems, especially with intra-articular administration, as well as with intradermal administration. |